Division of Developmental Disabilities Services Announces Data Breach; Call Center: 1-833-875-0644 (9 am - 9 pm Mon-Fri) Learn More
Current Suspected Overdose Deaths in Delaware for 2022: Get Help Now!
The Delaware Division of Public Health alerts the medical community of recently published information regarding Cephalosporin Resistant Gonorrhea.
The CDC is now seeing concerning patterns of decreased susceptibility to Cephalosporins in the treatment of gonorrhea (see http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6026a2.htm)
Although treatment failure has not been reported in the United States, decreased susceptibility and treatment failures documented in Asia, Norway & Japan, coupled with this organism’s ability to mutate and become resistant, raises possibilities that treatment failures are on the horizon in the United States.
Health care providers need to be aware of the potential for future resistance and take these important steps to ensure successful treatment outcomes for their patients:
For Additional Information about this or any other STD or to report a case, call the Delaware Division of Public Health, Sexually Transmitted Disease Program at (302) 744-1050 or visit our website at: http://www.dhss.delaware.gov/dhss/dph/dpc/stds.html.
You are receiving this email because you are a registered member of the Delaware Health Alert Network. If you are not a member and would like to subscribe, please register at https://healthalertde.org